Cyclazocine, a Long Acting Narcotic Antagonist: ITS Voluntary Acceptance as a Treatment Modality by Narcotics Abusers
International Journal of the Addictions · 1966
DOI: 10.3109/10826086609072275 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of the Addictions, 1966. Verfasst von Jerome H. Jaffe und 1 weiteren Autor:innen. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Martin and co-workers (1965b) have proposed that the regular administration of cyclazocine, a long acting narcotic antagonist, might be useful in the treatment of ambulatory patients who are highly motivated to avoid relapse to the compulsive use of narcotics. The purpose of this paper is twofold: 1) To present the pharmacology of cyclazocine and the rationale for its use in the treatment of narcotic addicts, and 2) To describe briefly the patients who have voluntarily accepted this form of treatment and our early experiences with them.
Zitieren
APA
Jaffe, J. H., & Brill, L. (1966). Cyclazocine, a Long Acting Narcotic Antagonist: ITS Voluntary Acceptance as a Treatment Modality by Narcotics Abusers. International Journal of the Addictions. https://doi.org/10.3109/10826086609072275
Vancouver
Jaffe JH, Brill L. Cyclazocine, a Long Acting Narcotic Antagonist: ITS Voluntary Acceptance as a Treatment Modality by Narcotics Abusers. International Journal of the Addictions. 1966. doi:10.3109/10826086609072275
BibTeX
@article{Jaffe1966,
author = {Jaffe, Jerome H. and Brill, Leon},
title = {Cyclazocine, a Long Acting Narcotic Antagonist: ITS Voluntary Acceptance as a Treatment Modality by Narcotics Abusers},
journal = {International Journal of the Addictions},
year = {1966},
doi = {10.3109/10826086609072275}
}
EUVIMED